Company news
Celcuity Inc. news in 2023
Celcuity Inc.'s news releases, calls and decks from 2023, newest first.
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
December 5, 2023
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
November 30, 2023
Celcuity to Participate in the 6th Annual Evercore ISI HealthCONx Conference
November 21, 2023
Celcuity Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 12, 2023
Celcuity Inc. Schedules Release of Third Quarter 2023 Financial Results and Webcast/Conference Call
November 5, 2023
Celcuity To Present at Upcoming Stifel and Jefferies Investor Conferences
October 31, 2023
Celcuity Inc. Announces $50 Million Private Placement
October 17, 2023
Celcuity to Host Virtual Science Day for Investors
September 6, 2023
Celcuity Enters into a Clinical Trial Collaboration and Supply Agreement with Bayer to Provide Nubeqa® (darolutamide) for Planned Phase 1b/2 Clinical Trial
August 21, 2023
Celcuity Announces Plan to Conduct Phase 1b/2 Clinical Trial in Metastatic Castration Resistant Prostate Cancer
August 21, 2023
Celcuity Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 9, 2023
Celcuity Inc. Schedules Release of Second Quarter 2023 Financial Results and Webcast/Conference Call
August 2, 2023
Celcuity to Participate in the BTIG Virtual Biotechnology Conference 2023
July 30, 2023
Celcuity Set to Join Russell 2000 and 3000 Indexes
June 19, 2023
Celcuity to Participate in Upcoming Craig-Hallum and Jefferies Investor Conferences
May 23, 2023
Celcuity Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 14, 2023
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress
May 11, 2023
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
May 7, 2023
Celcuity Inc. Schedules Release of First Quarter 2023 Financial Results and Webcast/Conference Call
May 7, 2023
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
April 17, 2023
Celcuity to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 22, 2023
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2022 Financial Results and Webcast/Conference Call
March 15, 2023
Celcuity to Present Preclinical Data on Therapeutic Effects of Gedatolisib in Gynecological Cancer Models at AACR Annual Meeting 2023
March 14, 2023
Celcuity to Participate in Cowen's 43rd Annual Health Care Conference
February 28, 2023
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Prostate Cancer at ASCO GU Cancers Symposium
February 15, 2023
Calls in 2023
Decks in 2023
- Investor Day (September 2023)
Investor day · 96 slides · Sep 21, 2023